Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | 3004044 | — |
The patient took the pills last minute and the box obtained from vendor had a short date on it and expired on 30-Nov-2024; The patient received only one dose of Vivotif, then realised that box expired; Case reference number US-BN-2024-002886 is a spontaneous case initially received from a pharmacist via Med Communications (reference number: USBAV24-3231) on 06-Dec-2024 and concerns a *31-years-old female patient (also reported as 25 years) *. The patient's medical history and concomitant medication details were not provided. On *29-Nov-2024*, the patient took first dose of Vivotif (batch number: *3004044* and expiration date: 30-Nov-2024), *at a dose of one capsule, orally, for indication reported as pre-travel* (explicitly coded as 'expired vaccine used'). The patient who picked up the vaccine two months ago and took the pills last minute and the box obtained from vendor had a short date on it and expired on 11/30. *As reported, the patient received only one dose of Vivotif, then realised that box expired (explicitly coded as 'incomplete course of vaccination') *. At the time of the *follow-up* report, the patient *did not* experience any adverse event due to Vivotif. All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*). Follow up information received from a pharmacist on 22-Jan-2025: New information included added patient demographics, Vivotif dosing details and confirmed that patient did not experience any adverse event due to Vivotif.; Reporter's Comments: A 31-year-old female patient (also reported as 25 years) took the first dose of Vivotif (expiration date: 30-Nov-2024) for unknown indication, which is considered as expired vaccine used. As reported, the patient received only one dose of Vivotif, then realised that box expired, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse event due to Vivotif. Expired product administered and incomplete course of vaccination are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Expired product administered and incomplete course of vaccination are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 31-year-old female patient (also reported as 25 years) took the first dose of Vivotif (expiration date: 30-Nov-2024) for unknown indication, which is considered as expired vaccine used. As reported, the patient received only one dose of Vivotif, then realised that box expired, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse event due to Vivotif. Expired product administered and incomplete course of vaccination are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Expired product administered and incomplete course of vaccination are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.